Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

OPK Relative to the S&P 500

OPK Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Opko Health Inc. (NASD:OPK) seasonal charts above shows that a Buy Date of April 25 and a Sell Date of July 23 has resulted in a geometric average return of 10.5% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 14 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 13.43% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko’s diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world?supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.

To download OPK seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: OPK